Navigation Links
Beckman Coulter Investor Events Second Half of 2008
Date:9/10/2008

ORANGE COUNTY, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

-- Q3 2008 Earnings Release scheduled for Tuesday, October 28, 2008. Q3

conference call scheduled for 5:00 p.m. ET.

-- Clinical Lab Tour: Investor Event scheduled for Thursday,

September 25, 2008, in Indianapolis, Indiana. For more information,

contact Beckman Coulter's Investor Relations Department at

(714) 773-7620.

-- Beckman Coulter 2008 Annual Business Review. The executive management

of the company will host one event in New York City, New York, on

Tuesday, December 16, 2008:

-- There will be a live webcast of this event. It will be accessible

through Beckman Coulter's website.

-- The company will attend the following conference:

-- Oppenheimer 19th Annual Healthcare Conference -- Tuesday,

November 4, 2008, in New York City, New York.

-- Lazard Capital Markets Healthcare Conference -- Tuesday,

November 18, 2008, New York City, New York.

-- Piper Jaffray Conference -- Tuesday, December 2, 2008, New York

City, New York.

-- RBC Conference -- Thursday, December 11, 2008, New York City, New

York.

Please refer to the company's website at '/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
2. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
3. Beckman Coulter Announces Second Quarter 2008 Results
4. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
5. Upcoming Beckman Coulter Investor Events Second Half of 2008
6. Beckman Coulter to Present at Upcoming Healthcare Conferences
7. Beckman Coulter Announces First Quarter 2008 Results
8. Beckman Coulter Acquires Rights to Hepatitis C Virus
9. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
10. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
11. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... are the basis for much of mankind,s technology, used ... week,s issue of the journal Nature (August ... industrial researchers from the UK, USA and Lesotho, report ... amount of another common metal, manganese, to create a ...
... announced,its 27th annual Inc. 500 ranking of the fastest-growing ... provider,MicroTech, ranks No. 285 on the list, with three-year ... measures revenue growth from 2004 through 2007.,To qualify, companies ... or divisions of other companies - and have had ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY) announced ... Nasdaq,Stock Market on August 14, 2008 indicating that ... listing on The NASDAQ Global Market,because it does ... things, that (i) the market value of Oncothyreon,s ...
Cached Biology Technology:Creating unconventional metals 2MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 3
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... stem cell that participates in the repair of the large ... protecting the body from infectious agents and toxins in the ... and clearing mucus from the airways. The mucus is largely ... mechanisms of normal and excessive mucus production are not well ...
... Thamma was taking classes at the University of Houston when ... enroll in an introductory course. "Taking this course quickly ... right away," Thamma said. "After enrolling in several courses, I ... years ago. Today, Thamma puts his education to work at ...
... N.Y. There will be some very interesting passengers ... Atlantis scheduled to launch July 8, 2011: thousands of ... and biological engineering at Rensselaer, is leading a series ... shuttle during its scheduled 12-day mission. The research seeks ...
Cached Biology News:UCLA stem cell scientists discover new airway stem cell 2University of Houston's Biotech Program gets state grant 2University of Houston's Biotech Program gets state grant 3Engineer to launch bacteria into space aboard the final mission of Space Shuttle Atlantis 2Engineer to launch bacteria into space aboard the final mission of Space Shuttle Atlantis 3
Donor feline serum and plasma...
Complete cell culture media with cytokines...
NPT1 (M-19)...
... cups provide flexible sealing lips for ... surfaces. ,PFG: Flat cup ,PBG: Bellows ... Multiple Bellows cup , Range ... 200 mm , Multiple suction cup ...
Biology Products: